Armata (NYSE: ARMP) investors approve board, pay plan and 2026 auditor
Rhea-AI Filing Summary
Armata Pharmaceuticals reported results from its annual shareholder meeting. Shareholders elected seven directors, each receiving about 28.3–28.5 million votes in favor, with relatively small withhold and broker non-vote totals.
Investors also approved, on a non-binding advisory basis, the compensation of the named executive officers with 28,547,283 shares voting for and modest opposition. Shareholders supported holding future advisory votes on executive pay every year, with 28,567,809 votes backing a one-year frequency. In addition, they ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, by 29,842,514 votes in favor.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Deborah L. Birx, M.D.: 28,349,266 shares
Votes for Daniel B. Gilmer, Ph.D.: 28,543,542 shares
Say-on-pay approval votes: 28,547,283 shares
+3 more
6 metrics
Votes for Deborah L. Birx, M.D.
28,349,266 shares
Director election at 2026 annual meeting
Votes for Daniel B. Gilmer, Ph.D.
28,543,542 shares
Director election at 2026 annual meeting
Say-on-pay approval votes
28,547,283 shares
Non-binding advisory vote on executive compensation
Say-on-pay frequency (one year)
28,567,809 shares
Preference for annual advisory vote on compensation
Auditor ratification votes for
29,842,514 shares
Ratification of Ernst & Young LLP for FY ending Dec 31, 2026
Broker non-votes director elections
1,257,467 shares
Consistent broker non-votes across all director nominees
Key Terms
non-binding advisory basis, broker non-votes, independent registered public accounting firm, frequency of future advisory votes
4 terms
non-binding advisory basis financial
"shareholders next approved, on a non-binding advisory basis, the compensation"
A non-binding advisory basis is guidance or a recommendation offered for informational purposes that does not create legal obligations or guarantees; recipients can accept, modify, or ignore it without contractual consequences. Investors should treat it like a weather forecast for planning—useful for forming expectations and assessing risk, but not a firm promise—so they should verify assumptions, seek confirming information, and avoid relying on it as the sole basis for investment decisions.
broker non-votes financial
"1,257,467 shares of broker non-votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratified the appointment of Ernst & Young LLP as our independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
frequency of future advisory votes financial
"the frequency of future advisory votes on the Company’s named executive officer compensation"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
Is the Armata Pharmaceuticals (ARMP) say-on-pay vote binding on the board?
The say-on-pay vote is non-binding and advisory, meaning it does not legally require changes. However, the strong approval of executive compensation provides feedback the board can consider when designing future pay programs and making compensation decisions for senior management.